Study procedure | Animal model | Cells | Major findings | Date | Ref. |
---|---|---|---|---|---|
-isolation of c-kitPOS cells -immunocytochemistry analysis -induction of MI -implantation of myocytes cells | rat | c-kitPOS cells | -improved of functional performance of the postinfarcted hearts injected with Lin(-) c-kitPOS cells | 2003 | [25] |
-using transgenic mice to determine the location of c-kitPOS cells in a healthy heart and in the heart after myocardial infarction | mouse | c-kitPOS cells | - the number of c-kitPOS cells is higher at birth compared to adults - an increased number of c-kitPOS cells was observed in the infarction region | 2008 | [32] |
-isolation of c-kitPOS cells with high GATA-4 expression -co-culture of c-kitPOS GATA-4 cells with adult cardiomyocytes | rat | c-kitPOS cells | -c-kitPOS GATA-4 cells affect cardiomyocyte survival by inducing IGF1R | 2010 | [33] |
-isolation of CDCs -induction of MI -intramyocardial injection of CDCs | pig | autologous CDCs | -preservation of left ventricular function - minimization of adverse ventricular remodeling | 2011 | [35] |
-isolation of CDCs from rat and human hearts -induction of MI in rats -intramyocardially CDCc injection in groups: syngenic group, allogenic group, xenogeneic group | rat | allogenic CDCs syngenic CDCs | -allogenic CDCs promotes cardiac regeneration -improvement in cardiac function was observed in rat models | 2012 | [36] |
-preparation of cardiospheres -injection cardiospheres in the peri-infarct zone | rat | allogenic CDCs | -reduced scar size -increased cardiac function | 2013 | [37] |
-induction of chronic infarction -intramyocardial injection of CSCs | dog | autologous CSCs | -less increase in left ventricular end-systolic volume -preservation of left ventricular ejection fraction | 2013 | [41] |
-induction of MI -intracoronary infusion of CDCs | pig | allogenic CDCs | -MRI is a useful tool for assessing dynamic changes in the infarct and monitoring regenerative efficacy -decreased scar size -increased myocardium viability | 2013 | [38] |
-isolation and culture of human MSCs and CSCs -induction of MI in pig -intramyocardial injection of MSCS and CSCs | pig | Xenogeneic MSCs and CSCs | -reduced scar size -restoration of diastolic and systolic function of the left ventricle | 2013 | [39] |
-development of the c-kitPOS cells isolation protocol | rat mouse | c-kitPOS cells | -identification and isolation of c-kitPOS cells | 2014 | [31] |
-isolation of CSCs cells -intracoronary infusion of autologous CSCs | pig | autologous CSCs | -improves regional and global left ventricular function -promotes cardiac and vascular regeneration in pigs with old MI | 2014 | [40] |
-preparation of CDCs -randomized -induction of MI -intracoronary administration of CDCs | pig | allogenic CDCs | -reduction of infract size -CDCs are effective in cardioprotection -prevention of microvascular obstruction | 2015 | [26] |
-isolation of human CSCs -identification of c-kitPOS cells with PIM1 overexpression -intramyocardial injection of CSCs to Yorkshire swine | pig | human CSCs | -PIM1 overexpression enhanced the effect of intramyocardial delivery of CSCs to infarcted porcine hearts -reduced scar size | 2017 | [34] |